Home Applications 077672 Application 077672
Type ANDA
Sponsor AUROBINDO PHARMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 STAVUDINE STAVUDINE CAPSULE;ORAL 30MG No No 002 STAVUDINE STAVUDINE CAPSULE;ORAL 40MG No No 003 STAVUDINE STAVUDINE CAPSULE;ORAL 15MG No No 004 STAVUDINE STAVUDINE CAPSULE;ORAL 20MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077672-001 STAVUDINE STAVUDINE 30MG CAPSULE / ORAL 2008-12-29 A077672-002 STAVUDINE STAVUDINE 40MG CAPSULE / ORAL 2008-12-29 A077672-003 STAVUDINE STAVUDINE 15MG CAPSULE / ORAL 2008-12-29 A077672-004 STAVUDINE STAVUDINE 20MG CAPSULE / ORAL 2008-12-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 5 of 5 · 176 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 A077672-001 STAVUDINE 30MG CAPSULE / ORAL 2008-12-29 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A077672-002 STAVUDINE 40MG CAPSULE / ORAL 2008-12-29 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A077672-003 STAVUDINE 15MG CAPSULE / ORAL 2008-12-29 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A077672-004 STAVUDINE 20MG CAPSULE / ORAL 2008-12-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A077672-001 STAVUDINE 30MG CAPSULE / ORAL 2008-12-29 e64feba35796…2022-09-29 23:25 UTC 2022-09 A077672-002 STAVUDINE 40MG CAPSULE / ORAL 2008-12-29 e64feba35796…2022-09-29 23:25 UTC 2022-09 A077672-003 STAVUDINE 15MG CAPSULE / ORAL 2008-12-29 e64feba35796…2022-09-29 23:25 UTC 2022-09 A077672-004 STAVUDINE 20MG CAPSULE / ORAL 2008-12-29 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A077672-001 STAVUDINE 30MG CAPSULE / ORAL 2008-12-29 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A077672-002 STAVUDINE 40MG CAPSULE / ORAL 2008-12-29 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A077672-003 STAVUDINE 15MG CAPSULE / ORAL 2008-12-29 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A077672-004 STAVUDINE 20MG CAPSULE / ORAL 2008-12-29 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A077672-001 STAVUDINE 30MG CAPSULE / ORAL 2008-12-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A077672-002 STAVUDINE 40MG CAPSULE / ORAL 2008-12-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A077672-003 STAVUDINE 15MG CAPSULE / ORAL 2008-12-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A077672-004 STAVUDINE 20MG CAPSULE / ORAL 2008-12-29 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 20 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 57237-234 Stavudine Stavudine Citron Pharma LLC ANDA Current 57237-235 Stavudine Stavudine Citron Pharma LLC ANDA Current 57237-236 Stavudine Stavudine Citron Pharma LLC ANDA Current 57237-237 Stavudine Stavudine Citron Pharma LLC ANDA Current 64980-354 Stavudine Stavudine Rising Pharmaceuticals, Inc. ANDA Current 64980-354 Stavudine Stavudine Rising Pharmaceuticals, Inc. ANDA Current 64980-355 Stavudine Stavudine Rising Pharmaceuticals, Inc. ANDA Current 64980-355 Stavudine Stavudine Rising Pharmaceuticals, Inc. ANDA Current 64980-356 Stavudine Stavudine Rising Pharmaceuticals, Inc. ANDA Current 64980-356 Stavudine Stavudine Rising Pharmaceuticals, Inc. ANDA Current 64980-357 Stavudine Stavudine Rising Pharmaceuticals, Inc. ANDA Current 64980-357 Stavudine Stavudine Rising Pharmaceuticals, Inc. ANDA Current 65862-046 Stavudine Stavudine Aurobindo Pharma Limited ANDA Current 65862-046 Stavudine Stavudine Aurobindo Pharma Limited ANDA Current 65862-047 Stavudine Stavudine Aurobindo Pharma Limited ANDA Current 65862-047 Stavudine Stavudine Aurobindo Pharma Limited ANDA Current 65862-111 Stavudine Stavudine Aurobindo Pharma Limited ANDA Current 65862-111 Stavudine Stavudine Aurobindo Pharma Limited ANDA Current 65862-112 Stavudine Stavudine Aurobindo Pharma Limited ANDA Current 65862-112 Stavudine Stavudine Aurobindo Pharma Limited ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 18468 ORIG 2009-02-04 31275 ORIG 2008-12-30 31274 ORIG 2006-07-03 31273 ORIG 2005-07-08